Insights
From stratospheric antennas to implantable bio-sensors, from the thermodynamics of carbon capture to quantum technology and AI-designed biology, we use deep tech to challenge and change the status quo.
Read our latest research and insights to help you see beyond the innovation hype and find out how emerging technologies are solving important business problems.
A potential gamechanger for the treatment of keratoconus
Deep tech consultants at Cambridge Consultants report on a potential gamechanger for the treatment of keratoconus, a challenging degenerative eye condition ...
A promising breakthrough in the fight against glaucoma blindness
What is glaucoma? It’s a condition that represents the leading cause of irreversible blindness worldwide. A team of CC scientists and engineers have made a promising breakthrough for the monitoring of interocular pressure (IOP), a major contributor to glaucoma ...
Biosolutions: The time is now
This exclusive Capgemini survey reveals that 96% of organisations are already embracing the disruption of biosolutions ...
Will wireless charging power a transformative future for implantable medical devices?
Wireless charging has the potential to be the go-to power solution for implantable medical devices as technology innovation makes them smaller and smarter ...
How to ensure quantum algorithms are purpose-built for business value creation
It’s a key time for quantum technology and quantum computing; success awaits those who ensure quantum algorithms are purpose-built for business value creation ...
Accelerating the adoption of omics in clinical medicine
Cambridge Consultants is spearheading efforts to realise the clinical potential of omics through deep tech in digital microfluidics, photonics and quantum sensors ...
The best under-invested medtech innovation opportunities
This is the year to put medtech investment to work. With macroeconomics improving, inflation easing and organizations stabilizing, now is the time to light the powder ...
Cracking genomics needs biology and engineering to find a common language
The first company to deploy cost-effective genomic measurements in mainstream medicine will not only transform healthcare, but also create lasting business value. But why has no-one cracked it yet? ...
The precision medicine industry must work together to transform rare disease treatment
Precision medicine is leading to transformative patient treatments – but industry collaboration is needed to make sure patients with rare diseases are not left behind ...
